Levitee Labs announces appointment of Dr Mohammed H. Mosli, as chief people officer of Levitee Clinics and Levitee Pharmacies

14 October, 2021

Levitee Labs announces appointment of Dr Mohammed H. Mosli, as chief people officer of Levitee Clinics and Levitee Pharmacies

In this role, the company said, Dr Mosli will oversee managing the strategy and processes related to building and retaining an exceptional team of professionals and will optimize people-centered activities such as hiring, training, professional development, and performance management of over 60 active employees in Alberta

Levitee Labs -
Levitee Labs noted that Dr Mosli is a multilingual Public Health and Preventive Medicine physician specialized in Addictions Health, health services improvement, health promotion, environmental public health, and health policy

Levitee Labs (CSE:LVT) Inc. has announced the appointment of Dr Mohammed H. Mosli, as the chief people officer (CPO) of Levitee Clinics and Levitee Pharmacies in Alberta, Canada.

In this role, the company said, Dr Mosli will oversee managing the strategy and processes related to building and retaining an exceptional team of professionals and will optimize people-centered activities such as hiring, training, professional development, and performance management of over 60 active employees in Alberta, to ensure these efforts support the continued growth of Levitee Clinics and Levitee Pharmacies across North America.

In a statement, Pouya Farmand, Levitee Labs chief executive officer said: “Dr Mosli has spent his career working with multi-disciplinary teams to provide focused medical care to vulnerable populations, including opioid agonist therapy, alcohol addiction therapy, Hepatitis C treatment, and many more. He exudes leadership and has consistently demonstrated unparalleled skills to organize teams and manage individuals at major organizations to achieve goals with the utmost efficiency, qualities that will be invaluable to us as we continue to roll-up companies and expand our operations nationwide.”

READ: Levitee Labs inks letter of intent to buy Calgary compounding pharmacy

 

Levitee Labs noted that Dr Mosli is a multilingual Public Health and Preventive Medicine physician specialized in Addictions Health, health services improvement, health promotion, environmental public health, and health policy. Throughout his career, he served, or currently serves as a director, educator, or senior level manager for an array of organizations, including those in provincial, institutional, and private segments. He is a physician member of the Opioid Addictions Medicine team for Levitee Clinics and Levitee Pharmacies in Alberta.

Dr Mosli commented: “I have always been passionate about leading innovation in reorienting health systems, increasing health equality, and protecting the wellbeing of local, national, and global population with an evidence-based approach. My goals align perfectly with those of Levitee Labs™ and I look forward to being a leader during this phase of rapid growth for the company.”

Dr Mosli earned his FRCPC (Fellow of the Royal College of Physicians of Canada) degree from the University of Calgary in Public Health and Preventive Medicine. He earned his Bachelor of Medicine and Bachelor of Surgery (MBBS) degree in the field of Medical Sciences from King Abdulaziz University in Saudi Arabia. He is fluent in written and spoken English and Arabic and has authored and/or presented more than a dozen peer-reviewed publications and presentations.

Levitee Labs is establishing itself as a leader in the integrative wellness space. Through leveraging an M&A regimen that focuses on the centralization of complementary integrative wellness assets, the company aims to transform mental health and addiction treatments through the integration of psychedelic medicines and therapies into a medical home care model.

Contact the author at jon.hopkins@proactiveinvestors.com

Learn more: Levitee Labs Appoints Dr. Mohammed Mosli as Chief People Officer of Levitee Clinics and Pharmacies in Alberta, Canada

Would you like to know more?

Contact us